drugset

drugset / Trial / NCT07509801

A Study to Evaluate the Safety and Efficacy of NT-88

NCT07509801 ↗

Not yet recruiting 60 enrolled Guangzhou Manjing biomedicine technology co., ltd

RandomizedParallel-groupSingle-blindTreatment

Summary

A study to evaluate the safety and preliminary efficacy of Zuozhu Daxi in patients with chronic heart failure with mildly reduced ejection fraction

Timeline

Start: 2026-03-30
Primary completion: 2027-02-25
Completion: 2027-06-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	NT-88	Unknown	—	—

Indications